期刊文献+

山莨菪碱联合血浆置换干预血栓性血小板减少性紫癜中血小板变化的研究 被引量:7

The observation of Platelet on plasma exchange combined with anisodamine in treatment of thrombotic thrombocytopenic purpura
暂未订购
导出
摘要 目的观察山莨菪碱联合血浆置换(PE)干预血栓性血小板减少性紫癜(TTP)后血小板(PLT)变化情况。方法选择60例TTP患者随机分组,联合干预组30例予山莨菪碱联合血浆置换(PE),疗程21天;对照组30例予以PE干预,疗程21天。结果联合干预组21天后有效率93%,对照组有效率90%,差异有显著性(P<0.05),血小板(PLT)在治疗后第2、5、12数值上升速度明显快于对照组,差异有显著性(P<0.05),有统计学意义,第21天,差异无显著性(P>0.05)。结论血浆置换联合山莨菪碱注射液对血栓性血小板减少性紫癜血小板数值恢复加快,可以判断患者的预后。 Objective To investigate the clinic efficacy and safety of plasma exchange (PE) combined with aniso- damine administration in the treatment of thrombotic thrombocytopenic purpura (TTP). Methods 60 patients were randomized into two groups,each group contained 30 patients,the treatment group is given anisodamine injection com- bined with plasma exchange(PE) ,and the period of treatment is 21 days; the controlled group is just given plasma ex- change and the period is also 21 days. Results The efficacy of the combined treatment group for 21 days is 93%, the controlled group is 90 % ,there were significant difference between tow groups(P〈0.05). The speed of the ascension of platelet after treatm.ent for 2,5 and 12 days is obviously more rapid than the controlled group, there were significant difference(P〈0.05) ,and there is statistic meaning. However the contrast of the result of the 21st day shows no signifi- cant difference (P〉0.05). Conclusion Anisodamine combined with plasma exchange shows better clinic effect and no more hemorrhagic risk than plasma exchange in therapy of thrombotic thrombocytopenic purpura.
出处 《中国实验诊断学》 2013年第2期314-316,共3页 Chinese Journal of Laboratory Diagnosis
关键词 血栓性血小板减少性紫癜 血浆置换 血小板 山莨菪碱 Thrombotic thrombocytopenic purpura Therapeutic plasma exchange platelet Anisodamine
  • 相关文献

参考文献8

  • 1Rock G,Porta C,Bobbi2Pallavicini E. Thrombotic thrombocytopenic purpura treatment in year 2000[J].Haematologica,2000.410.
  • 2张之南.血液病诊断及疗效标准[S]北京:北京科学技术出版社,1998285-289.
  • 3Kakishta E. Pathophysiology and treatment of thrombotic thrombocy2topenic purpura/hemolytic syndrome (TTP/HUS)[J].Int J Hematolo2gy,2000.320.
  • 4Moake J L,Chow T W. Thrombotic thrombocytopenic purpura:under2standing a diseatse nl longer rare[J].American Journal of the Medical Sciences,1998.105.
  • 5曾晓颖,沈志祥.血栓性血小板减少性紫癜的发病机理和有关实验室检查的评价[J].内科急危重症杂志,1996,2(3):129-129. 被引量:3
  • 6Mitra D,kimJ,Maclow C. Role of caspases 1 and 3 and Bcl-2 relat2ed molecules in endothelial cell apoptosis associated with thromboticmicroangiopathies[J].American Journal of Hematology,1998.279.
  • 7Bandarenko N,Brecher M E. Multicenter survey and retrospectiveanalysis of current efficacy of therapeutic plasma exchange[J].J ClinApheresis,1998.133.
  • 8汪明性.药理学[M]北京:人民卫生出版社.

共引文献2

同被引文献47

  • 1张文华,贾文玲,周子英,唐海涛,王凤梅.无肝素血浆置换治疗肝功能衰竭的方法及安全性探讨[J].临床肝胆病杂志,2012,28(1):50-52. 被引量:6
  • 2唐万欣,付平,崔天蕾,高玉春,黄颂敏.无肝素抗凝技术在连续性静脉-静脉血液滤过中的应用[J].中国实用内科杂志,2006,26(7):995-997. 被引量:20
  • 3汪明性.药理学[M].4版.北京:人民卫生出版社,1997:208.
  • 4MewarD, Wilson A G. Auto- antibodies inrheuma- toidarthritis: a review[J]. Biomed Phamacother, 2006, 60 (10): 648.
  • 5Duffy S M, Coyle T E. Platelet transfusions and bleeding complications associated with plasma exchange catheter place- ment in patients with presumed thrombotic thrornbocytopenic purpura[J]. J Clin Apher, 2013, 28(5): 356.
  • 6Femdndez - Pajarin G, Arias - Rivas S, Pias - Peleteiro J M. Aphasia and thromboeytopenic thrombotic purpura in a young woman: the platelet count dilemma[J ]. Rev Neurol, 2013, 57(7): 335.
  • 7LubanS, Li Z G. Citrullinated peptide and its relevance to rheumatoid arthritis: an update[J]. Int J RheumDis, 2010, 13(4) : 284.
  • 8Furuya T, Matsumoto I, Tsuchiya N, et al. Anti- glucose 6 - phosphate isomerase, anti - cyclic citrullinated peptide antibodies and HLA - DRB1 genotypes in Japanese patients with early rheumatoid arthritis [J ]. Clin Exp Rheumatol, 2008, 26(5): 918.
  • 9Shah N, Rutherford C, Matevosyan K, et al. Role of ADAMTSI3 in the management of thrombotic microan- giopathies including thrombotic thrombocytopenic purpura (TTP)[J]. BrJ Haematol, 2013, 163(4): 514.
  • 10Manro M, Kim J, Costello C, et al. Role of transforming growth factor betal in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic uremie syndrome[J]. Am J Hematol, 2001, 66 (1): 12.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部